CGL
AGIO icon

Clarius Group LLC’s Agios Pharmaceuticals AGIO Stock Holding History

Clarius Group LLC’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-109,230
Closed -$7.29M – 68
2017
Q3 		$7.29M Hold
109,230
– – 3.07% 5
2017
Q2 		$5.62M Hold
109,230
– – 2.32% 5
2017
Q1 		$6.38M Hold
109,230
– – 2.63% 5
2016
Q4 		$4.56M Hold
109,230
– – 1.93% 8
2016
Q3 		$5.77M Buy
109,230
+61,564
+129% +$2.68M 2.69% 5
2016
Q2 		$2M Hold
47,666
– – 1.06% 15
2016
Q1 		$1.94M Buy
+47,666
New +$2.04M 1.07% 18

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Clarius Group LLC's AGIO Position: Q4 2017 in Review

Clarius Group LLC sold out of Agios Pharmaceuticals (AGIO) in Q4 2017, closing a stake of 109,230 shares — an estimated $7.29M sold.

Clarius Group LLC first reported a position in AGIO in Q1 2016 and held it in 7 quarters. The position peaked at $7.29M in Q3 2017. 178 funds tracked by Wall St. Rank hold AGIO as of Q4 2017.

  • Clarius Group LLC reported no remaining Agios Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Clarius Group LLC sold 109,230 Agios Pharmaceuticals shares in Q4 2017, an estimated $7.29M.
  • Clarius Group LLC first reported a position in Agios Pharmaceuticals in Q1 2016 and held it in 7 quarters.
  • Clarius Group LLC's Agios Pharmaceuticals position peaked at $7.29M in Q3 2017.
  • 178 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2017.

Based on Clarius Group LLC's 13F filing for Q4 2017, filed 9 Feb 2018.